Literature DB >> 18485336

Low dose IL-15 induces snap arming of CD44(low) T lymphocytes in the absence of antigen.

David L Tamang1, Bryce N Alves, Viki Elliott, Stephanie A Fraser, Doug Redelman, Dorothy Hudig.   

Abstract

It is widely accepted that naïve T cells require two signals, antigen recognition and co-simulation, to become cytotoxic over the course of 3-5days. However, we observed that freshly isolated murine splenocytes without exposure to antigen become cytotoxic within 24h after culture with IL-15. IL-15 is a cytokine that promotes homeostatic proliferation, maintenance and activation of memory T cells. The induced cytotoxicity, measured by anti-CD3 redirected (51)Cr release, represented the combined activity of T cells regardless of their antigen specificity, and proceeded even when CD44(hi) (memory-associated phenotype) CD8(+) T cells were depleted. Cytotoxic capacity was perforin-dependent and occurred without detectable up-regulation of granzyme B or cell division. After induction, the phenotypic markers for the memory subset and for activation remained unchanged from the expression of resting T cells. Our work suggests that T cells may gain cytotoxic potential earlier than currently thought and even without TCR stimulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485336      PMCID: PMC2613908          DOI: 10.1016/j.cellimm.2008.04.007

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  43 in total

1.  Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells.

Authors:  Tontanai Numbenjapon; Lisa M Serrano; Wen-Chung Chang; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

2.  Modified histogram subtraction technique for analysis of flow cytometry data.

Authors:  W R Overton
Journal:  Cytometry       Date:  1988-11

3.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.

Authors:  D Kägi; B Ledermann; K Bürki; P Seiler; B Odermatt; K J Olsen; E R Podack; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

4.  Effects of interleukin-15 on in vitro human T cell proliferation and activation.

Authors:  M S Hasan; E G Kallas; E K Thomas; J Looney; M Campbell; T G Evans
Journal:  J Interferon Cytokine Res       Date:  2000-02       Impact factor: 2.607

5.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

Authors:  J A Johnston; M Kawamura; R A Kirken; Y Q Chen; T B Blake; K Shibuya; J R Ortaldo; D W McVicar; J J O'Shea
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

6.  Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.

Authors:  B A Witthuhn; O Silvennoinen; O Miura; K S Lai; C Cwik; E T Liu; J N Ihle
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

7.  Immune function in mice lacking the perforin gene.

Authors:  C M Walsh; M Matloubian; C C Liu; R Ueda; C G Kurahara; J L Christensen; M T Huang; J D Young; R Ahmed; W R Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

9.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Authors:  W E Carson; J G Giri; M J Lindemann; M L Linett; M Ahdieh; R Paxton; D Anderson; J Eisenmann; K Grabstein; M A Caligiuri
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

Authors:  O Lantz; A Bendelac
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  1 in total

1.  Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.

Authors:  Sharon Wei Ling Lee; Giulia Adriani; Erica Ceccarello; Andrea Pavesi; Anthony Tanoto Tan; Antonio Bertoletti; Roger Dale Kamm; Siew Cheng Wong
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.